News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

John G. Fort

Articles by John G. Fort

Cyclooxygenase-2-Specific Inhibitors and Cardiorenal Function: A Randomized, Controlled Trial of Celecoxib and Rofecoxib in Older Hypertensive Osteoarthritis Patients

ByAndrew Whelton,John G. Fort,Joseph A. Puma,Diane Normandin,Alfonso E. Bello,Kenneth M. Verburg, for the SUCCESS VI Study Group (Reprinted from Th

October 1st 2002

Latest Updated Articles

Cyclooxygenase-2-Specific Inhibitors and Cardiorenal Function: A Randomized, Controlled Trial of Celecoxib and Rofecoxib in Older Hypertensive Osteoarthritis Patients
Published: October 1st 2002 | Updated:

Trending on AJMC

HERIZON-GEA-01 Results Indicate Potential 1L Use of Zanidatamab for Gastroesophageal Adenocarcinoma

USDA and HHS Update Dietary Guidelines to Encourage Real Food, Less Sugar

Social Determinants of Health Linked to Worse Outcomes in Hypertrophic Cardiomyopathy

CDC Vaccine Rollback Highlights Gaps in Public Understanding of Shared Decision-Making

β-Blockers Show No Added Benefit After MI With Preserved LVEF

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.